Case File
efta-efta00872266DOJ Data Set 9OtherFrom: Jeffrey Epstein <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00872266
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <[email protected]>
To: Melanie Spinella
Subject: Fwd: Funding a GRAT with encumbered property
Date: Wed, 16 Oct 2013 18:14:52 +0000
HHHHHHHEEEEEEELLLLLLLLPPPPPPIIIIIIIIIIII
Forwarded message -----
From: Ada Clapp <1
Date: Wed, Oct 16, 2013 at 2:06 PM
Subject: Funding a GRAT with encumbered property
To: Jeffrey Epstein <[email protected]>
Cc: Eileen Alexanderson
Jeffrey,
Regarding the GRAT, to summarize my discussions with Alan, as I understand it, there is still an issue to resolve
regarding the BFP interests as it is currently collateral for the 2006 Trust loan. Funding a GRAT with assets
pledged for Leon's personal obligation is not so clear cut. In short:
I.
There is some concern that the gift to the GRAT would be incomplete given that there is a risk (albeit
slight) of forfeiture of the assets if Leon defaults on the loan from the 2006 Trust. We may be able to take care of
this with a side agreement between Leon and the GRAT (which I think would also solve any valuation issues
resulting from the risk of loss). Alan is still considering this option.
2.
Alan is also exploring the option of having the 2006 Trust release the BFP interests as collateral in exchange
for Leon giving the 2006 Trust a secured interest in his annuity payments. This might work while Leon is alive
but may cause a problem if Leon dies during the GRAT term. There is some concern that this arrangement may
disqualify the GRAT since the amount of the annuity payable to Leon or his estate would be uncertain and
because GRAT property is not permitted to be paid to anyone other than Leon or his estate).
FYI--Alan and I spent some time looking into the viability of funding the GRAT with a derivative as you
suggested. This too is not clear cut and raised several issues, including the risk of an incomplete gift, a step
transaction if we funded with cash and had the GRAT trustee purchase the derivative contracts, whether Section
7520 could be used to calculate the annuity since the asset has a speculative value (resulting in the risk of an
under-valutaion gift that would not adjust via an annuity increase). I believe Alan turned to the encumbered
property issues once he understood that you were willing to forgo funding with a derivative.
Best regards,
Ada Clapp
Black Family Partners
do Apollo Mana °meal
IRS Circular 230 Disclosure:
Pursuant to IRS regulations, I inform you that any tax advice contained in this communication
(including attachments) is not intended or written to be used, and cannot be used by any person or
entity for the purpose of (i) avoiding tax related penalties imposed by any governmental tax authority,
EFTA00872266
or (ii) promoting, marketing or recommending to another party any transaction or matter discussed
herein. I advise you to consult with an independent tax advisor on your particular tax circumstances.
This communication, and any attachment, is for the intended recipient(s) only and may contain
information that is privileged, confidential and/or proprietary If you are not the intended recipient, you
are hereby notified that further dissemination of this communication and its attachments is prohibited.
Please delete all copies of this communication and its attachments and notify me immediately that
you have received them in error.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00872267
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.